Designing and conducting interventional trials with passive-sensing applications on patient-owned smartphones: challenges and recommendations from the BD4QoL study - Summary - MDSpire

Designing and conducting interventional trials with passive-sensing applications on patient-owned smartphones: challenges and recommendations from the BD4QoL study

  • By

  • Francesco Giuliani

  • Laura Lopez-Perez

  • Franco Mercalli

  • Tessa Fulton-Lieuw

  • Claudia Vener

  • Francesco Ricciardi

  • Michela Falcone

  • Antonio Mangiacotti

  • Stefano Cavalieri

  • Antonello Manocchio

  • Elena Martinelli

  • Luca Maria Lacerenza

  • Chiara Copelli

  • Despina Elizabeth Filippidou

  • Aritz Bilbao

  • Aitor Almeida

  • Hisham Mehanna

  • Giuseppe Fico

  • Lisa Licitra

  • July 13, 2026

Share

Objective:

To report key lessons from the BD4QoL multicenter randomized clinical trial (RCT) regarding the implementation of a digital platform for monitoring quality of life in head and neck cancer survivors.

Approach:
  • Trial Execution Challenges: The paper describes challenges encountered during trial execution, including device heterogeneity, reliance on third-party apps, regulatory concerns, and methodological barriers.
  • BYOD Deployment: It examines the challenges of conducting a multicenter randomized trial based on passive sensing and a Bring Your Own Device (BYOD) approach.
Key Findings:
  • Digital health technologies can support cancer survivorship but introduce methodological and operational complexities.
  • Issues such as patient recruitment, adherence, technical reliability, and data integration into clinical workflows frequently emerge.
  • Existing literature highlights barriers in using patient-owned mobile technologies for remote monitoring.
Interpretation:

Limitations:
  • Variability in patients' ability to engage with digital technologies.
  • Possible exclusion of patients using specific smartphone devices or operating systems.
  • Limitations in continuity of data collection and standardization.
Conclusion:

The study emphasizes the need for rigorous investigation and validation of digital health interventions in oncology.

Original Source(s)

Related Content